Liver retransplantation demonstrates limited benefit in acquired transthyretin amyloidosis, suggesting timely intervention is crucial.
Liver retransplantation appears to offer limited benefit in halting disease progression in acquired ATTR amyloidosis, particularly when performed at advanced stages. Earlier intervention, before the establishment of significant systemic involvement, may improve outcomes. These findings highlight the need for timely diagnosis and individualized management in this underrecognized condition.
No takes yet. Share an insight, caveat, or question.
Duarte et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: